SPINE 润色咨询

SPINE

出版年份:1976 年文章数:16432 投稿命中率: 开通期刊会员,数据随心看

出版周期:Biweekly 自引率:12.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2017-04-05 毅然盛开

    给了稿号也得等3周才能送审185****0045暂无昵称 2017-03-19 发表::
    给编号说明什么?不是还得审吗…

    185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2017-03-19 1851e92ff2m

    给编号说明什么?不是还得审吗…SCI狂魔 2016-07-22 发表::
    投了三篇,当天给的稿件编号

    SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-12-15 ms3041982178615389

    比较容易发表

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-11-18 ms3212165295344000

    审稿速度:1.0
    经验分享:编辑处理的效率还可以,送审快

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-10-31 1e14a5b0m77(暂无匿称)

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-10-16 1e0b9de5m54(暂无匿称)

    临床应用价值高,发表率高

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-10-08 1e128d2fm65(暂无匿称)

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:这是脊柱外科级别较高的了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-08-17 ms5054295132918558

    审稿速度:3.0
    经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-07-22 SCI狂魔

    投了三篇,当天给的稿件编号

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=535132, encodeId=e5e2535132eb, content=给了稿号也得等3周才能送审<span class="quote">185****0045暂无昵称 2017-03-19 发表::<br>给编号说明什么?不是还得审吗…</span>, beContent=185****0045暂无昵称 2017-03-19 发表:: 给编号说明什么?不是还得审吗…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=293, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/05/2e09374a63b79e081026ee14d641777c.jpg, createdBy=84071987328, createdName=毅然盛开, createdTime=Wed Apr 05 01:09:00 CST 2017, time=2017-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534439, encodeId=c7a453443981, content=给编号说明什么?不是还得审吗…<span class="quote">SCI狂魔 2016-07-22 发表::<br>投了三篇,当天给的稿件编号</span>, beContent=SCI狂魔 2016-07-22 发表:: 投了三篇,当天给的稿件编号, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bb7e2038710, createdName=1851e92ff2m, createdTime=Sun Mar 19 15:01:00 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834973, encodeId=38d58349e3c0, content=比较容易发表 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a365413975, createdName=ms3041982178615389, createdTime=Thu Dec 15 15:40:13 CST 2016, time=2016-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834643, encodeId=93be83464308, content=审稿速度:1.0<br>经验分享:编辑处理的效率还可以,送审快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Fri Nov 18 17:28:45 CST 2016, time=2016-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528843, encodeId=196652884325, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享:发了一篇,一直再用boss的通讯作者者邮箱操作,后发现自己第一作者看不到稿件进展信息了,进boss号看到作者状态自己有一栏写着拒绝,怎么办,急,求大神指导, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1b1965768, createdName=1e14a5b0m77(暂无匿称), createdTime=Mon Oct 31 12:23:00 CST 2016, time=2016-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=528290, encodeId=5db352829040, content=临床应用价值高,发表率高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160824/IMG57BDA6843F0F38922.jpg, createdBy=8fdd1925645, createdName=1e0b9de5m54(暂无匿称), createdTime=Sun Oct 16 11:27:00 CST 2016, time=2016-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=527972, encodeId=838552e972d3, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:这是脊柱外科级别较高的了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Sat Oct 08 08:05:00 CST 2016, time=2016-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833161, encodeId=e71c83316122, content=审稿速度:3.0<br>经验分享:脊柱领域质量上乘的杂志,值得国人一试,比较重视新颖。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Wed Aug 17 17:48:55 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525061, encodeId=58fd5250616b, content=投了三篇,当天给的稿件编号, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=203, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b8201739791, createdName=SCI狂魔, createdTime=Fri Jul 22 06:07:00 CST 2016, time=2016-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=523343, encodeId=d887523343f5, content=meta分析投稿3天稿件编号不知道会不会悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fde21654247, createdName=沧海一声笑9437, createdTime=Sun Jun 12 08:06:00 CST 2016, time=2016-06-12, status=1, ipAttribution=)]
    2016-06-12 沧海一声笑9437

    meta分析投稿3天稿件编号不知道会不会悲剧

    0

共110条页码: 5/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分